Celcuity LLC (CELC)
Fair Value-41.5% Downside
Overvalued
Analyst91.0% Upside
Market Cap4.115 B
P/E—
Yield0.0%
HealthWeak
NASDAQ
Cellectis SA (CLLS)
Fair Value10.3% Upside
Fair
Analyst241.3% Upside
Market Cap115.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Cogent Biosciences Inc (COGT)
Fair Value-1.1% Downside
Fair
Analyst71.1% Upside
Market Cap5.664 B
P/E—
Yield0.0%
HealthWeak
NASDAQ
Collplant Biotechnologies Ltd (CLGN)
Fair Value34.6% Upside
Undervalued
Market Cap7.28 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Corbus Pharmaceuticals Holding (CRBP)
Fair Value11.3% Upside
Fair
Analyst331.8% Upside
Market Cap152.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Corvus Pharmaceuticals Inc (CRVS)
Fair Value-4.8% Downside
Fair
Analyst146.6% Upside
Market Cap1.131 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Crispr Therapeutics AG (CRSP)
Fair Value-26.3% Downside
Overvalued
Analyst48.3% Upside
Market Cap5.708 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Cue Biopharma (CUE)
Fair Value26.8% Upside
Undervalued
Analyst184.8% Upside
Market Cap224.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Momentum
Cypherpunk Technologies Inc (CYPH)
Fair Value-40.1% Downside
Overvalued
Analyst31.4% Upside
Market Cap402 M
P/E—
Yield0.0%
HealthGreat
NASDAQ
Featured in
Bullish Trend Stocks
CytomX Therapeutics Inc (CTMX)
Fair Value-9.9% Downside
Fair
Analyst316.7% Upside
Market Cap640.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
DBV Technologies (DBVT)
Fair Value-12.1% Downside
Fair
Analyst211.0% Upside
Market Cap725 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Decoy Therapeutics Inc (DCOY)
Fair Value32.8% Upside
Undervalued
Analyst867.7% Upside
Market Cap2.031 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Denali Therapeutics Inc (DNLI)
Fair Value9.5% Upside
Fair
Analyst67.0% Upside
Market Cap3.453 B
P/E—
Yield0.0%
HealthWeak
NASDAQ
Editas Medicine Inc (EDIT)
Fair Value-2.5% Downside
Fair
Analyst105.5% Upside
Market Cap448.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Ensysce Biosciences Inc (ENSC)
Fair Value45.4% Upside
Undervalued
Market Cap8.347 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Entera Bio Ltd (ENTX)
Fair Value-38.9% Downside
Overvalued
Analyst202.0% Upside
Market Cap516 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Fennec Pharmaceuticals Inc (FENC)
Fair Value14.7% Upside
Fair
Analyst60.5% Upside
Market Cap386.1 M
P/E—
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Fortress Biotech Inc Pref Series A (FBIOP)
Fair Value6.1% Upside
Fair
Market Cap81.71 M
P/E0.8x
Yield0.0%
HealthGreat
NASDAQ
Forum Markets, Inc (FRMM)
Fair Value54.1% Upside
Bargain
Analyst88.9% Upside
Market Cap66.391 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Genprex Inc (GNPX)
Fair Value22.8% Upside
Undervalued
Market Cap2.902 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Immunitybio Inc (IBRX)
Fair Value-19.4% Downside
Overvalued
Analyst37.2% Upside
Market Cap9.846 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Immuron Ltd ADR (IMRN)
Fair Value35.6% Upside
Undervalued
Analyst216.8% Upside
Market Cap10.57 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Indaptus Therapeutics Inc (INDP)
Fair Value-48.5% Downside
Overvalued
Analyst150.6% Upside
Market Cap531.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
Bullish Trend Stocks
Low-Float Small-Cap Momentum Stocks
High-Growth Small-Cap Stocks
Under $10 per Share
InflaRx N.V. (IFRX)
Fair Value-7.3% Downside
Fair
Analyst276.1% Upside
Market Cap306.5 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Insight Molecular Diagnostics Inc (IMDX)
Fair Value7.3% Upside
Fair
Analyst99.3% Upside
Market Cap135.5 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Intellia Therapeutics Inc (NTLA)
Fair Value11.7% Upside
Fair
Analyst89.3% Upside
Market Cap1.778 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Kala Pharmaceuticals Inc (KALA)
Fair Value2.4% Upside
Fair
Market Cap11.585 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Kiniksa Pharmaceuticals Ltd (KNSA)
Fair Value-7.9% Downside
Fair
Analyst25.6% Upside
Market Cap6.086 B
P/E75.6x
Yield0.0%
HealthGreat
NASDAQ
Krystal Biotech Inc (KRYS)
Fair Value0.4% Upside
Fair
Analyst10.0% Upside
Market Cap10.386 B
P/E40.9x
Yield0.0%
HealthGreat
NASDAQ
Kura Oncology Inc (KURA)
Fair Value-7.0% Downside
Fair
Analyst172.8% Upside
Market Cap1.044 B
P/E—
Yield0.0%
HealthWeak
NASDAQ
Kyntra Bio Inc (KYNB)
Fair Value20.3% Upside
Undervalued
Analyst444.9% Upside
Market Cap29.478 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Lunai Bioworks Inc (LNAI)
Fair Value-47.8% Downside
Overvalued
Market Cap10.111 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Marker Therapeutics Inc (MRKR)
Fair Value44.7% Upside
Undervalued
Analyst544.8% Upside
Market Cap20.341 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Mereo BioPharma Group PLC ADR (MREO)
Fair Value3.1% Upside
Fair
Analyst525.8% Upside
Market Cap50.51 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Mesoblast Ltd (MESO)
Fair Value0.3% Upside
Fair
Analyst132.4% Upside
Market Cap1.996 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Moleculin Biotech Inc (MBRX)
Fair Value14.7% Upside
Fair
Market Cap11.005 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Mustang Bio Inc (MBIO)
Fair Value48.8% Upside
Undervalued
Market Cap4.023 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Natera Inc (NTRA)
Fair Value-43.3% Downside
Overvalued
Analyst-10.9% Downside
Market Cap56.346 B
P/E—
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
NuCana PLC (NCNA)
Fair Value37.1% Upside
Undervalued
Market Cap5.732 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ocugen, Inc (OCGN)
Fair Value-12.3% Downside
Fair
Market Cap356.1 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Organogenesis Holdings Inc (ORGO)
Fair Value3.8% Upside
Fair
Analyst35.1% Upside
Market Cap190.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
OUTLOOK THERAPEUTICS INC (OTLK)
Fair Value-28.5% Downside
Overvalued
Analyst622.0% Upside
Market Cap169.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ovid Therapeutics Inc (OVID)
Fair Value-16.1% Downside
Fair
Analyst114.3% Upside
Market Cap539 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Palvella Therapeutics Inc (PVLA)
Fair Value-11.1% Downside
Fair
Analyst45.8% Upside
Market Cap2.278 B
P/E—
Yield0.0%
HealthFair
NASDAQ
PDS Biotechnology Corp (PDSB)
Fair Value14.0% Upside
Fair
Analyst422.0% Upside
Market Cap50.934 M
P/E—
Yield0.0%
HealthFair
NASDAQ
ProQR Therapeutics NV (PRQR)
Fair Value15.8% Upside
Fair
Analyst332.7% Upside
Market Cap268.1 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Protagonist Therapeutics Inc (PTGX)
Fair Value-12.9% Downside
Fair
Analyst20.3% Upside
Market Cap9.387 B
P/E113.3x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks